215 related articles for article (PubMed ID: 28489923)
1. Differences of microparticle patterns between sickle cell anemia and hemoglobin SC patients.
Garnier Y; Ferdinand S; Etienne-Julan M; Elana G; Petras M; Doumdo L; Tressières B; Lalanne-Mistrih ML; Hardy-Dessources MD; Connes P; Romana M
PLoS One; 2017; 12(5):e0177397. PubMed ID: 28489923
[TBL] [Abstract][Full Text] [Related]
2. Plasma concentration of platelet-derived microparticles is related to painful vaso-occlusive phenotype severity in sickle cell anemia.
Nebor D; Bowers A; Connes P; Hardy-Dessources MD; Knight-Madden J; Cumming V; Reid M; Romana M
PLoS One; 2014; 9(1):e87243. PubMed ID: 24475257
[TBL] [Abstract][Full Text] [Related]
3. Association Between Nitric Oxide, Oxidative Stress, Eryptosis, Red Blood Cell Microparticles, and Vascular Function in Sickle Cell Anemia.
Nader E; Romana M; Guillot N; Fort R; Stauffer E; Lemonne N; Garnier Y; Skinner SC; Etienne-Julan M; Robert M; Gauthier A; Cannas G; Antoine-Jonville S; Tressières B; Hardy-Dessources MD; Bertrand Y; Martin C; Renoux C; Joly P; Grau M; Connes P
Front Immunol; 2020; 11():551441. PubMed ID: 33250889
[TBL] [Abstract][Full Text] [Related]
4. Erythrocyte microparticles can induce kidney vaso-occlusions in a murine model of sickle cell disease.
Camus SM; Gausserès B; Bonnin P; Loufrani L; Grimaud L; Charue D; De Moraes JA; Renard JM; Tedgui A; Boulanger CM; Tharaux PL; Blanc-Brude OP
Blood; 2012 Dec; 120(25):5050-8. PubMed ID: 22976952
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of circulating blood and endothelial cell microparticles in sickle-cell disease.
Kasar M; Boğa C; Yeral M; Asma S; Kozanoglu I; Ozdogu H
J Thromb Thrombolysis; 2014; 38(2):167-75. PubMed ID: 24254379
[TBL] [Abstract][Full Text] [Related]
6. Sickle cell disease: A distinction of two most frequent genotypes (HbSS and HbSC).
da Guarda CC; Yahouédéhou SCMA; Santiago RP; Neres JSDS; Fernandes CFL; Aleluia MM; Figueiredo CVB; Fiuza LM; Carvalho SP; Oliveira RM; Fonseca CA; Ndidi US; Nascimento VML; Rocha LC; Goncalves MS
PLoS One; 2020; 15(1):e0228399. PubMed ID: 31995624
[TBL] [Abstract][Full Text] [Related]
7. Microparticles in sickle cell disease.
Romana M; Connes P; Key NS
Clin Hemorheol Microcirc; 2018; 68(2-3):319-329. PubMed ID: 29614639
[TBL] [Abstract][Full Text] [Related]
8. Exacerbation of oxidative stress during sickle vaso-occlusive crisis is associated with decreased anti-band 3 autoantibodies rate and increased red blood cell-derived microparticle level: a prospective study.
Hierso R; Lemonne N; Villaescusa R; Lalanne-Mistrih ML; Charlot K; Etienne-Julan M; Tressières B; Lamarre Y; Tarer V; Garnier Y; Hernandez AA; Ferracci S; Connes P; Romana M; Hardy-Dessources MD
Br J Haematol; 2017 Mar; 176(5):805-813. PubMed ID: 27984639
[TBL] [Abstract][Full Text] [Related]
9. The acceleration of the propagation phase of thrombin generation in patients with steady-state sickle cell disease is associated with circulating erythrocyte-derived microparticles.
Gerotziafas GT; Van Dreden P; Chaari M; Galea V; Khaterchi A; Lionnet F; Stankovic-Stojanovic K; Blanc-Brude O; Woodhams B; Maier-Redelsperger M; Girot R; Hatmi M; Elalamy I
Thromb Haemost; 2012 Jun; 107(6):1044-52. PubMed ID: 22535498
[TBL] [Abstract][Full Text] [Related]
10. Circulating platelet and erythrocyte microparticles in young children and adolescents with sickle cell disease: Relation to cardiovascular complications.
Tantawy AA; Adly AA; Ismail EA; Habeeb NM; Farouk A
Platelets; 2013; 24(8):605-14. PubMed ID: 23249216
[TBL] [Abstract][Full Text] [Related]
11. Abnormality of erythrocyte membrane n-3 long chain polyunsaturated fatty acids in sickle cell haemoglobin C (HbSC) disease is not as remarkable as in sickle cell anaemia (HbSS).
Ren H; Ghebremeskel K; Okpala I; Ugochukwu CC; Crawford M; Ibegbulam O
Prostaglandins Leukot Essent Fatty Acids; 2006 Jan; 74(1):1-6. PubMed ID: 16314081
[TBL] [Abstract][Full Text] [Related]
12. Decrease of externalized phosphatidylserine density on red blood cell-derived microparticles in SCA patients treated with hydroxycarbamide.
Garnier Y; Ferdinand S; Connes P; Garnier M; Etienne-Julan M; Lemonne N; Romana M
Br J Haematol; 2018 Aug; 182(3):448-451. PubMed ID: 28653368
[No Abstract] [Full Text] [Related]
13. Elevated plasma levels and platelet-associated expression of the pro-thrombotic and pro-inflammatory protein, TNFSF14 (LIGHT), in sickle cell disease.
Garrido VT; Proença-Ferreira R; Dominical VM; Traina F; Bezerra MA; de Mello MR; Colella MP; Araújo AS; Saad ST; Costa FF; Conran N
Br J Haematol; 2012 Sep; 158(6):788-97. PubMed ID: 22775554
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of hypoxemia among children with sickle cell anemia during steady state and crises: a cross-sectional study.
Chinawa JM; Ubesie AC; Chukwu BF; Ikefuna AN; Emodi IJ
Niger J Clin Pract; 2013; 16(1):91-5. PubMed ID: 23377479
[TBL] [Abstract][Full Text] [Related]
15. Kidney Disease among Patients with Sickle Cell Disease, Hemoglobin SS and SC.
Drawz P; Ayyappan S; Nouraie M; Saraf S; Gordeuk V; Hostetter T; Gladwin MT; Little J
Clin J Am Soc Nephrol; 2016 Feb; 11(2):207-15. PubMed ID: 26672090
[TBL] [Abstract][Full Text] [Related]
16. Plasma annexin A5 and microparticle phosphatidylserine levels are elevated in sickle cell disease and increase further during painful crisis.
van Tits LJ; van Heerde WL; Landburg PP; Boderie MJ; Muskiet FA; Jacobs N; Duits AJ; Schnog JB
Biochem Biophys Res Commun; 2009 Dec; 390(1):161-4. PubMed ID: 19799864
[TBL] [Abstract][Full Text] [Related]
17. Impact of splenectomy on circulating microparticles in patients with sickle cell anemia.
Boulassel MR; Al-Rubkhi K; Al-Qasabi J; El-Ghamry I; Khan H; Panjwani V; Qureshi RN; Al-Mamari S; Al-Qarni Z; Al-Kindi M; Al-Nabhani A; Al-Gharibi K; Wali Y; Pathare A
Int J Lab Hematol; 2024 Feb; 46(1):141-147. PubMed ID: 37661331
[TBL] [Abstract][Full Text] [Related]
18. Polymorphisms in genes that affect the variation of lipid levels in a Brazilian pediatric population with sickle cell disease: rs662799 APOA5 and rs964184 ZPR1.
Valente-Frossard TNS; Cruz NRC; Ferreira FO; Belisario AR; Pereira BM; Gomides AFF; Resende GAD; Carlos AM; Moraes-Souza H; Velloso-Rodrigues C
Blood Cells Mol Dis; 2020 Feb; 80():102376. PubMed ID: 31670185
[TBL] [Abstract][Full Text] [Related]
19. Novel permeability characteristics of red blood cells from sickle cell patients heterozygous for HbS and HbC (HbSC genotype).
Dalibalta S; Ellory JC; Browning JA; Wilkins RJ; Rees DC; Gibson JS
Blood Cells Mol Dis; 2010 Jun; 45(1):46-52. PubMed ID: 20227897
[TBL] [Abstract][Full Text] [Related]
20. Plasma microparticles of sickle patients during crisis or taking hydroxyurea modify endothelium inflammatory properties.
Garnier Y; Ferdinand S; Garnier M; Cita KC; Hierso R; Claes A; Connes P; Hardy-Dessources MD; Lapouméroulie C; Lemonne N; Etienne-Julan M; El Nemer W; Romana M
Blood; 2020 Jul; 136(2):247-256. PubMed ID: 32285120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
